RIGENERAND SRL
RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications.Founded in 2009 by Prof. Massimo Dominici and Prof. Pierfranco Conte, as a spin-off resulting from a joint venture between biomedical company RanD and researchers from the University of Modena and Reggio Emilia, Rigenerand owns proprietary technology to develop and produce biomedical tools to empower the ex-vivo phase of stem cells expansion combining the need of high cell yield with innovative biocompatible materials.
RIGENERAND SRL
Industry:
Biopharma Biotechnology Health Care Medical Device
Founded:
2009-01-01
Address:
Medolla, Emilia-Romagna, Italy
Country:
Italy
Website Url:
http://www.rigenerand-biotech.com
Total Employee:
11+
Status:
Active
Contact:
+39053549307
Email Addresses:
[email protected]
Total Funding:
8.7 M EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS WordPress Grid Shutterstock Django CSRF Contabo Register.IT DNS
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Employees Featured
Founder
Investors List
Principia SGR
Principia SGR investment in Venture Round - Rigenerand Srl
Official Site Inspections
http://www.rigenerand-biotech.com Semrush global rank: 3.95 M Semrush visits lastest month: 3.14 K
- Host name: 37.208.110.243
- IP address: 37.208.110.243
- Location: Frankfurt am Main Germany
- Latitude: 50.1382
- Longitude: 8.6183
- Timezone: Europe/Berlin
- Postal: 60488
More informations about "Rigenerand Srl"
ABOUT US - Rigenerand
Founded as spin-off of the University of Modena and Reggio Emilia, Rigenerand is a joint venture between RanD, a biomedical company producing bioreactors for liver support and chemo …See details»
Rigenerand - Steps Ahead In Cell Technology
May 30, 2022 · Rigenerand is developing and producing cGMP products for cell-gene therapy together with tailored 3D culture biomedical devices for diagnostic and therapeutical applicationsSee details»
Rigenerand Srl - Crunchbase Company Profile & Funding
Rigenerand owns proprietary technology to develop and produce biomedical tools to empower the ex-vivo phase of stem cells expansion combining the need of high cell yield with innovative …See details»
Rigenerand srl - LinkedIn
Rigenerand srl | 2,245 followers on LinkedIn. Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl.See details»
Rigenerand Company Profile 2024: Valuation, Investors
Developer of biomedical devices designed to support the culture of stem cells for pre-clinical and clinical applications.See details»
CELL FACTORY - Rigenerand
Rigenerand wants to be a partner to develop and produce cell and gene therapy to address unmet clinical needs in compliance with highest regulatory standards.See details»
Evotec completes acquisition of Rigenerand
Jul 5, 2022 · Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the strategic transaction to acquire Rigenerand Srl, …See details»
Evotec acquires Rigenerand Srl - 2022-05-30 - Crunchbase
May 30, 2022 · Biotech Finances — The German CDMO Evotec (EVT) acquires 100% of the capital of the Italian Rigenerand for 23M€.See details»
Evotec Completes Acquisition of Rigenerand - BioSpace
Jul 5, 2022 · Based out of Medolla, Italy, the cell technology company with leading edge in the field of cGMP manufacturing of cell therapies will operate as Evotec (Modena) Srl going forward.See details»
Rigenerand launches CDMO gene therapy biz - Bioprocess Insider
Rigenerand launches CDMO biz after gene therapy facility gains approval. Regulatory approval to make gene therapies from its site in Modena, Italy has enabled biotech Rigenerand SRL to …See details»
October 12, 2021 Outsourced Pharma: Creating The …
Oct 12, 2021 · Massimo Dominici is co-founder of Rigenerand, a cell-and-gene therapy (CGT) company in Modena, Italy; full-time professor at University of Modena and Riggio Emilia; advisor to the World Health Organization ( WHO ); …See details»
Bone Therapeutics and Rigenerand sign partnership for cell …
Jan 14, 2021 · Rigenerand will contribute to improving the processes involved in the development and manufacture of Bone Therapeutics’ MSC based allogeneic differentiated cell therapy …See details»
Rigenerand Develops 3D Bioreactor for Extracellular Vesicle …
Jul 31, 2020 · Rigenerand, a Modena, Italy-based biotech company specializing in medicinal products for cell therapy applications, has begun development of a novel 3D bioreactor and …See details»
Rigenerand receives regulatory approval for gene therapy …
Jun 3, 2020 · Rigenerand is developing RR001, a proprietary ATMP gene therapy medicinal product for the treatment of pancreatic ductal adenocarcinoma (PDAC). RR001 has been …See details»
rigenerand-biotech.com Reviews: Is this site a scam or legit?
With its medium trust score on our chart, we determined it has a low risk. We determined this score by aggregating 53 powerful factors to expose high-risk activity and see if rigenerand …See details»
Rigenerand commences 3D bioreactor development for cGMP …
Rigenerand SRL is a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and oncology and 3D …See details»
Italian Startup Rigenerand Homes in on Mesenchymal Cells for …
Aug 12, 2021 · NEW YORK – Italian startup Rigenerand is hoping to start a first-in-human clinical trial of its autologous, mesenchymal stromal cell (MSC)-based gene therapy in pancreatic …See details»
3D CULTURE TECHNOLOGIES - Rigenerand
Rigenerand develops and produces biomedical technology to empower cell culture combining the need of high yield with innovative biocompatible materials. to amplify human cells starting from …See details»
Bone Therapeutics and Rigenerand sign partnership for cell
Jan 14, 2021 · Rigenerand SRL is a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and …See details»
Rigenerand commences 3D bioreactor development for cGMP …
Jul 8, 2020 · Rigenerand SRL is a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and …See details»